By leveraging the TCGA database and immunohistochemical staining, we have demonstrated a robust upregulation of MAT1A in NSCLC tissues, underscoring its potential as a prognostic indicator. The gene discussed is MAT1A; the disease is non-small cell lung carcinoma.